| 产品名称: | Amycolatopsis mediterranei (Margalith and Beretta) Lechevalier et al. |
|---|---|
| 商品货号: | TS208171 |
| Deposited As: | Streptomyces mediterranei Margalith and Beretta |
| Strain Designations: | RS/20 |
| Application: | Produces rifamycin SV |
| Biosafety Level: | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format: | freeze-dried |
| Disclosure: | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Preceptrol®: | no |
| Type Strain: | no |
| Medium: | ATCC® Medium 196: Yeast malt extract agar |
| Growth Conditions: | Temperature: 26.0°C |
| Name of Depositor: | Gruppo Lepetit S.p.A. |
| U.S. Patent Number: | |
| References: | Lancini G, Hengeller C. Preparation of the antibiotic rifamycin SV. US Patent 3,597,324 dated Aug 3 1971 Lechevalier MP, et al. Two new genera of nocardioform Actinomycetes: Amycolata gen. nov. and Amycolatopsis gen. nov.. Int. J. Syst. Bacteriol. 36: 29-37, 1986. |